CR2/CD21 proximal promoter activity is critically dependent on a cell type-specific repressor

被引:20
|
作者
Ulgiati, D
Holers, VM
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80262 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA
来源
JOURNAL OF IMMUNOLOGY | 2001年 / 167卷 / 12期
关键词
D O I
10.4049/jimmunol.167.12.6912
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Transcription of the human complement receptor type 2 (CR2/CD21) gene is controlled by both proximal promoter and intronic elements. CR2 is primarily expressed on B cells from the immature through mature cell stages. We have previously described the presence of an intronic element that is required for both cell- and stage-specific expression of CR2. In this study, we report the identification of a cell type-specific repressor element within the proximal promoter. This repressor sequence is shown by linker scanning mutagenesis to comprise an E box motif. By supershift analysis this element binds members of the basic helix-loop-helix family of proteins, in particular E2A gene products. Mutational analysis demonstrates that binding of E2A proteins is critical for functioning of this repressor. Thus, E2A activity is key not only for early B cell development, but also for controlling CR2 expression, a gene expressed only during later stages of ontogeny.
引用
收藏
页码:6912 / 6919
页数:8
相关论文
共 50 条
  • [31] Solution studies of the complement receptor 2 (CR2/CD21) - C3d interaction reveals a charged CR2 interaction site
    Hannan, JP
    Young, KA
    Rengasamy, A
    Szakonyi, G
    Chen, XS
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 240 - 241
  • [32] Relative Impact of Complement Receptors CD21/35 (Cr2/1) on Scrapie Pathogenesis in Mice
    Kane, Sarah J.
    Swanson, Eric
    Gordon, Elizabeth O.
    Rocha, Savannah
    Bender, Heather R.
    Donius, Luke R.
    Aguzzi, Adriano
    Hannan, Jonathan P.
    Zabel, Mark D.
    MSPHERE, 2017, 2 (06):
  • [33] Expression of human complement receptor 2 (CR2, CD21) in Cr2-/- mice restores humoral immune function
    Marchbank, KJ
    Watson, CC
    Ritsema, DF
    Holers, VM
    JOURNAL OF IMMUNOLOGY, 2000, 165 (05): : 2354 - 2361
  • [34] Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-β binding in B cells
    Cruickshank, Mark N.
    Fenwick, Emily
    Karimi, Mahdad
    Abraham, Lawrence J.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2009, 46 (13) : 2613 - 2622
  • [35] B cell expression of the complement receptor 2 (CR2/CD21) constitutes a novel biomarker for COVID-19 severity
    Marcos-Jimenez, Ana
    Delgado-Wick, Pablo
    Diaz-Fernandez, Paula
    Montes, Nuria
    Fernandez-Lazaro, Iris
    Andreu-Martinez, Rosa M.
    Lopez, Noelia
    Cuesta-Mateos, Carlos
    Munoz-Calleja, Cecilia
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1680 - 1680
  • [36] Characterization of human complement receptor type 2 (CR2/CD21) as a receptor for IFN-α:: A potential role in systemic lupus erythematosus
    Asokan, Rengasamy
    Hua, Jing
    Young, Kendra A.
    Gould, Hannah J.
    Hannan, Jonathan P.
    Kraus, Damian M.
    Szakonyi, Gerda
    Grundy, Gabrielle J.
    Chen, Xiaojiang S.
    Crow, Mary K.
    Holers, V. Michael
    JOURNAL OF IMMUNOLOGY, 2006, 177 (01): : 383 - 394
  • [37] Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development
    Kulik, Liudmila
    Marchbank, Kevin J.
    Lyubchenko, Taras
    Kuhn, Kristine A.
    Liubchenko, Ganna A.
    Haluszczak, Catherine
    Gibson, Matthew G.
    Boackle, Susan A.
    Holers, V. Michael
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (03) : 623 - 633
  • [38] Site-directed mutagenesis of human CR2/CD21 in conjunction with C3d
    Hannan, JP
    Young, KA
    Asokan, R
    Gerda, SI
    Chen, XJ
    Holers, VM
    FASEB JOURNAL, 2003, 17 (07): : C108 - C108
  • [39] Isolating the Epstein-Barr virus gp350/220 binding site on complement receptor type 2 (CR2/CD21)
    Young, Kendra A.
    Chen, Xiaojiang S.
    Holers, V. Michael
    Hannan, Jonathan P.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (50) : 36614 - 36625
  • [40] Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21)
    Hess, MW
    Schwendinger, MG
    Eskelinen, EL
    Pfaller, K
    Pavelka, M
    Dierich, MP
    Prodinger, WM
    BLOOD, 2000, 95 (08) : 2617 - 2623